4.8 Article

Extending genetic risk for Alzheimer's disease from host to holobiont

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice

Yu Jiang et al.

Summary: Research has shown that in the early stages of Alzheimer's disease progression, the use of sodium butyrate can reduce the secretion of pro-inflammatory cytokines by inhibiting histone deacetylase (HDAC), thereby improving synaptic plasticity in 5XFAD mice.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Article Biology

Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition

Alessio Vittorio Colombo et al.

Summary: Microbiota-derived SCFA play a critical role in promoting A beta deposition in Alzheimer's disease by modulating the microglial phenotype along the gut-brain axis.

ELIFE (2021)

Article Neurosciences

Gut Microbiota is Altered in Patients with Alzheimer's Disease

Zhen-Qian Zhuang et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Clinical Neurology

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease

Nicholas M. Vogt et al.

ALZHEIMERS RESEARCH & THERAPY (2018)